Does Lipitor Interact with MAOIs?
Lipitor (atorvastatin), a statin for lowering cholesterol, has no established direct interactions with monoamine oxidase inhibitors (MAOIs), a class of antidepressants like phenelzine or selegiline. Standard drug interaction databases, including those from the FDA and manufacturers, do not flag pharmacokinetic or pharmacodynamic conflicts between atorvastatin and MAOIs.[1][2]
What About Indirect Risks or Patient Factors?
MAOIs carry a high risk of hypertensive crisis from tyramine-rich foods or sympathomimetic drugs, but Lipitor does not contain tyramine or affect monoamine metabolism in ways that trigger this. No case reports link the combination to serotonin syndrome, rhabdomyolysis, or altered statin efficacy. Patients on both should monitor for general statin side effects like muscle pain, as MAOIs alone can cause orthostatic hypotension, potentially complicating mobility-related statin use.[3]
Are Routine Precautions Needed?
No specific precautions beyond standard Lipitor guidelines (e.g., avoid grapefruit juice, check liver enzymes). Consult a doctor or pharmacist for individual cases, especially with selegiline (a selective MAO-B inhibitor used in Parkinson's), where high doses might overlap with statin metabolism via CYP3A4—though evidence shows minimal impact.[1][4]
How Do Other Statins Compare with MAOIs?
Similar profile for lovastatin, simvastatin, and rosuvastatin; no MAOI-specific warnings. Pravastatin, not metabolized by CYP enzymes, poses even less theoretical risk.[2]
Sources
[1]: Drugs.com Interaction Checker
[2]: FDA Lipitor Label
[3]: Lexicomp Drug Interactions
[4]: PubMed Review on MAOIs and CYP Interactions